vs

Side-by-side financial comparison of Alexandria Real Estate Equities (ARE) and Dexcom (DXCM). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $671.0M, roughly 1.9× Alexandria Real Estate Equities). Alexandria Real Estate Equities runs the higher net margin — 59.4% vs 21.2%, a 38.1% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -11.5%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -6.4%).

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust (REIT), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million square feet (SF). The asset base in North America includes 31.9...

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

ARE vs DXCM — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.9× larger
DXCM
$1.3B
$671.0M
ARE
Growing faster (revenue YoY)
DXCM
DXCM
+33.1% gap
DXCM
21.6%
-11.5%
ARE
Higher net margin
ARE
ARE
38.1% more per $
ARE
59.4%
21.2%
DXCM
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-6.4%
ARE

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ARE
ARE
DXCM
DXCM
Revenue
$671.0M
$1.3B
Net Profit
$398.4M
$267.3M
Gross Margin
62.9%
Operating Margin
25.6%
Net Margin
59.4%
21.2%
Revenue YoY
-11.5%
21.6%
Net Profit YoY
740.6%
153.6%
EPS (diluted)
$2.10
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARE
ARE
DXCM
DXCM
Q1 26
$671.0M
$1.3B
Q4 25
$754.4M
$1.3B
Q3 25
$751.9M
$1.2B
Q2 25
$762.0M
$1.2B
Q1 25
$758.2M
$1.0B
Q4 24
$788.9M
$1.1B
Q3 24
$791.6M
$994.2M
Q2 24
$766.7M
$1.0B
Net Profit
ARE
ARE
DXCM
DXCM
Q1 26
$398.4M
$267.3M
Q4 25
$-1.1B
$267.3M
Q3 25
$-232.8M
$283.8M
Q2 25
$-107.0M
$179.8M
Q1 25
$-8.9M
$105.4M
Q4 24
$-62.2M
$151.7M
Q3 24
$167.9M
$134.6M
Q2 24
$46.7M
$143.5M
Gross Margin
ARE
ARE
DXCM
DXCM
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
ARE
ARE
DXCM
DXCM
Q1 26
25.6%
Q4 25
25.6%
Q3 25
20.1%
Q2 25
18.4%
Q1 25
12.9%
Q4 24
17.0%
Q3 24
15.3%
Q2 24
15.7%
Net Margin
ARE
ARE
DXCM
DXCM
Q1 26
59.4%
21.2%
Q4 25
-143.3%
21.2%
Q3 25
-31.0%
23.5%
Q2 25
-14.0%
15.5%
Q1 25
-1.2%
10.2%
Q4 24
-7.9%
13.6%
Q3 24
21.2%
13.5%
Q2 24
6.1%
14.3%
EPS (diluted)
ARE
ARE
DXCM
DXCM
Q1 26
$2.10
$0.67
Q4 25
$-6.35
$0.67
Q3 25
$-1.38
$0.70
Q2 25
$-0.64
$0.45
Q1 25
$-0.07
$0.27
Q4 24
$-0.38
$0.37
Q3 24
$0.96
$0.34
Q2 24
$0.25
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARE
ARE
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$418.7M
$917.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$19.4B
$2.7B
Total Assets
$34.2B
$6.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARE
ARE
DXCM
DXCM
Q1 26
$418.7M
$917.7M
Q4 25
$549.1M
$917.7M
Q3 25
$579.5M
$1.8B
Q2 25
$520.5M
$1.2B
Q1 25
$476.4M
$904.9M
Q4 24
$552.1M
$606.1M
Q3 24
$562.6M
$621.2M
Q2 24
$561.0M
$939.2M
Total Debt
ARE
ARE
DXCM
DXCM
Q1 26
Q4 25
$12.4B
Q3 25
$13.6B
Q2 25
$13.3B
Q1 25
$13.1B
Q4 24
$12.2B
Q3 24
$12.7B
Q2 24
$12.4B
Stockholders' Equity
ARE
ARE
DXCM
DXCM
Q1 26
$19.4B
$2.7B
Q4 25
$15.5B
$2.7B
Q3 25
$16.6B
$2.7B
Q2 25
$17.2B
$2.6B
Q1 25
$17.5B
$2.3B
Q4 24
$17.9B
$2.1B
Q3 24
$18.2B
$2.0B
Q2 24
$18.3B
$2.4B
Total Assets
ARE
ARE
DXCM
DXCM
Q1 26
$34.2B
$6.3B
Q4 25
$34.1B
$6.3B
Q3 25
$37.4B
$7.5B
Q2 25
$37.6B
$7.3B
Q1 25
$37.6B
$6.8B
Q4 24
$37.5B
$6.5B
Q3 24
$38.5B
$6.4B
Q2 24
$37.8B
$6.8B
Debt / Equity
ARE
ARE
DXCM
DXCM
Q1 26
Q4 25
0.80×
Q3 25
0.82×
Q2 25
0.77×
Q1 25
0.75×
Q4 24
0.68×
Q3 24
0.70×
Q2 24
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARE
ARE
DXCM
DXCM
Operating Cash FlowLast quarter
$475.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
76.0%
Cash ConversionOCF / Net Profit
1.19×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARE
ARE
DXCM
DXCM
Q1 26
$475.0M
Q4 25
$312.4M
$294.0M
Q3 25
$433.5M
$659.9M
Q2 25
$460.2M
$303.0M
Q1 25
$207.9M
$183.8M
Q4 24
$274.2M
$301.4M
Q3 24
$477.4M
$199.5M
Q2 24
$411.8M
$279.4M
Free Cash Flow
ARE
ARE
DXCM
DXCM
Q1 26
Q4 25
$192.1M
Q3 25
$579.4M
Q2 25
$208.9M
Q1 25
$96.8M
Q4 24
$176.8M
Q3 24
$88.3M
Q2 24
$213.3M
FCF Margin
ARE
ARE
DXCM
DXCM
Q1 26
Q4 25
15.3%
Q3 25
47.9%
Q2 25
18.1%
Q1 25
9.3%
Q4 24
15.9%
Q3 24
8.9%
Q2 24
21.2%
Capex Intensity
ARE
ARE
DXCM
DXCM
Q1 26
76.0%
Q4 25
8.1%
Q3 25
6.7%
Q2 25
8.1%
Q1 25
8.4%
Q4 24
11.2%
Q3 24
11.2%
Q2 24
6.6%
Cash Conversion
ARE
ARE
DXCM
DXCM
Q1 26
1.19×
Q4 25
1.10×
Q3 25
2.33×
Q2 25
1.69×
Q1 25
1.74×
Q4 24
1.99×
Q3 24
2.84×
1.48×
Q2 24
8.82×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARE
ARE

Same properties$431.4M64%
Tenant recoveries$178.2M27%
Non-same properties$43.3M6%
Other$18.0M3%

DXCM
DXCM

Segment breakdown not available.

Related Comparisons